Loading clinical trials...
Loading clinical trials...
Randomised Study to Evaluate the Effect of Early Intervention to Treat Anemia With Epoetin Alfa Versus Standard Use on Hemoglobin Levels and the Incidence of Blood Transfusions in Cancer Patients Receiving Chemotherapy
Conditions
Interventions
epoetin alfa
Start Date
August 1, 2003
Completion Date
September 1, 2006
Last Updated
May 19, 2011
NCT07213804
NCT07169851
NCT07159659
NCT00026884
NCT06662786
NCT07481851
Lead Sponsor
Janssen-Cilag B.V.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions